Sep 27, 2022 7:00 am EDT BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference
Sep 7, 2022 7:00 am EDT BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14
Sep 1, 2022 9:00 am EDT Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
Aug 25, 2022 3:49 pm EDT Giving Metabolism A Boost? BioRestorative Uses Science Surrounding Brown Fat Cells To Provide A Possible Breakthrough In Metabolic Disorders
Jun 30, 2022 7:30 am EDT BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Jun 22, 2022 7:30 am EDT BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Jun 13, 2022 7:00 am EDT BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Apr 29, 2022 8:00 am EDT BioRestorative Therapies Hosts Principal Investigator Meeting for its BRTX-100® Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Apr 18, 2022 8:00 am EDT BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
Apr 4, 2022 8:00 am EDT BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification